If you're nervous about starting a GLP-1 medication for the first time, one of the smartest questions you can ask isn't just "will this work for me?" — it's "how is this actually made, and who's watching that process?" That's a fair, grown-up question, and you deserve real answers.

This article is educational and is not medical advice. Whether any medication is appropriate for you is a decision only an independent, licensed provider can make with you.

First, what "compounded" even means

A compounded medication is one that a specialized pharmacy prepares to meet a specific patient need — for example, when a commercially manufactured product isn't available in the form a patient needs, or during a documented shortage. Compounding is legal and long-standing, but it is regulated differently from mass-manufactured drugs.

Here's the part every first-timer should hear clearly, without spin:

> Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.

The FDA has been public about this distinction, noting that it has received adverse-event reports tied to compounded semaglutide products and reminding the public that compounded versions do not carry the same federal review as approved drugs [1][2]. That's not a reason to panic — it's a reason to ask specific questions about the pharmacy behind your vial.

503A vs. 503B: the difference that actually matters

Under federal law, there are two kinds of compounding pharmacies, and the difference tells you a lot about oversight.

  • 503A pharmacies compound medications for an individual patient based on a specific prescription. They're primarily overseen by state boards of pharmacy and are expected to follow standards like USP <797> for sterile preparations [3][4].
  • 503B outsourcing facilities register voluntarily with the FDA, can produce larger batches, and are held to Current Good Manufacturing Practice (CGMP) — the same broad quality framework that governs conventional drug manufacturers. The FDA inspects them and publishes a public registry of registered outsourcing facilities [3][5].

Why does this matter for the vial in your hand? Because an injectable is a *sterile* product going directly under your skin. The bar for how it's made, tested, and documented should be high. Knowing whether your medication came from a 503A pharmacy or a 503B outsourcing facility helps you understand what layer of oversight applied to it [3][5].

Two regulatory paths for compounding
State-led503A pharmaciesOverseen primarily by state boards of pharmacy
FDA-registered503B facilitiesHeld to CGMP; FDA-inspected
Public503B registryListed on FDA.gov

Source: [3] FDA: Compounding Laws and Policies (503A and 503B), [5] FDA: Registered Outsourcing Facilities (503B)

Sterility: what "sterile compounding" is supposed to guarantee

Any injectable must be free of harmful microbes and contaminants. That's what sterility standards exist to protect. The United States Pharmacopeia's General Chapter <797> sets the framework for compounding sterile preparations — covering things like cleanroom air quality, personnel gowning and hand hygiene, and the maximum time a compounded sterile product can be used before it must be discarded (its "beyond-use date") [4].

For sterility itself, USP General Chapter <71> describes the compendial sterility test used to demonstrate that a preparation is free of viable microorganisms [6]. And because a contaminated injectable can cause serious infection, endotoxin (bacterial-fragment) testing also matters for certain products [4][6].

The reason these standards exist isn't theoretical. The FDA continues to warn about the safety risks of poorly made compounded products and about counterfeit and unregulated "semaglutide" sold outside legitimate supply chains [1][2]. Knowing your medication passed real sterility testing — and came from a legitimate, inspected facility — is exactly the reassurance you're entitled to seek.

What sterile-compounding oversight covers (no dosing)
1Cleanroom controlsAir quality & environment per USP <797>
2Personnel practicesGowning & hand hygiene
3Sterility testingCompendial test per USP <71>
4Beyond-use dateDiscard-by limit assigned

Source: [4] USP General Chapter <797> Pharmaceutical Compounding — Sterile Preparations, [6] USP General Chapter <71> Sterility Tests

What semaglutide is (so you understand what's in the vial)

Semaglutide belongs to a class called GLP-1 receptor agonists. GLP-1 (glucagon-like peptide-1) is a hormone your gut naturally releases after eating; these medications mimic that signaling, which influences appetite and blood-sugar regulation [7][8]. Understanding the mechanism can take some of the mystery out of it — this isn't magic, it's a molecule interacting with receptors your body already has.

If the idea of an injection makes you queasy — and for plenty of people it genuinely does — that's worth saying out loud to a provider. GLP-1 medications come in more than one route in the broader marketplace, including oral formulations of some molecules, and a provider can talk through what forms may or may not be appropriate for your situation [7]. If you're breastfeeding or postpartum, that's a critical detail to raise; data in pregnancy and lactation is limited, and any medication decision in that window belongs entirely to you and your provider [7].

The questions worth asking before you inject anything

You don't need to be a pharmacist to advocate for yourself. Here's a short, plain list you can bring to a visit:

1. Is this from a 503A pharmacy or a 503B outsourcing facility? [3][5]

2. Was the product sterility tested, and to what standard (USP <71>)? [6]

3. What sterile-compounding standard does the pharmacy follow (USP <797>)? [4]

4. What is the beyond-use date, and how should it be stored? [4]

5. Is this pharmacy in good standing with its state board and, if a 503B, listed on the FDA registry? [3][5]

6. What are the known side effects, and who do I call if I feel unwell? [1][7]

A legitimate operation should be able to answer these without hesitation. If anyone dodges them — or sells "semaglutide" with no prescription, no provider, and no clear pharmacy — treat that as a stop sign [1][2].

A word on side effects and honest expectations

Nausea, vomiting, diarrhea, and constipation are among the most commonly reported gastrointestinal effects of GLP-1 receptor agonists [7][8]. More serious risks exist and are described in FDA labeling for approved products; those are conversations for a provider who knows your history [7]. Nobody can promise you a specific result, and this article makes no such promise. What we can say is that being informed about how your medication is made is part of using it responsibly.

Where Velri fits

Velri is not a medical practice and does not provide medical care. Velri is a technology and coordination company. What that means in practice: Velri can help coordinate lab work, connect you with an independent, licensed provider for a real conversation where your questions actually get heard, and — *if and only if* that provider decides a prescription is appropriate — coordinate fulfillment through an independent, licensed pharmacy. A prescription is never guaranteed; that decision belongs solely to the provider.

If you've spent years being rushed through seven-minute visits and handed a pamphlet, the goal here is different: time to ask the how-is-this-made questions, and a clear path to understanding the answers.

*This content is educational and is not medical advice, diagnosis, or a recommendation to take any specific medication. Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.*